GeneDx Holdings Corp. (WGS) stock
WGSNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3058% above fair value
$51.02−1.35 (-2.58%)
Close on Nov 16, 2026Market cap $1.52BP/E –Yield –
GeneDx EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
GeneDx's EV/EBITDA was 141.8× on Jan 30, 2026.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 141.8× | −51.7 |
| 2025 | Dec 31, 2025 | 193.5× | – |
See a number that looks wrong?